Emmert Daniel A, Fee Judy A, Goeckeler Zoe M, Grojean Jeremy M, Wakatsuki Tetsuro, Elson Elliot L, Herring B Paul, Gallagher Patricia J, Wysolmerski Robert B
Department of Pathology, Saint Louis University School of Medicine, 1402 S. Grand Blvd., St. Louis, MO 63104, USA.
Am J Physiol Cell Physiol. 2004 Jan;286(1):C8-21. doi: 10.1152/ajpcell.00428.2002. Epub 2003 Sep 10.
Thus far, determining the relative contribution of Ca2+/calmodulin-dependent myosin light chain kinase (MLCK) and Ca2+-independent Rho-kinase pathways to myosin II activation and contraction has been difficult. In this study, we characterize the role of Rho-kinase in a rat embryo fibroblast cell line (REF-52), which contains no detectable MLCK. No endogenous MLCK could be detected in REF-52 cells by either Western or Northern blot analysis. In the presence or absence of Ca2+, thrombin or lysophosphatidic acid (LPA) increased RhoA activity and Rhokinase activity, correlating with isometric tension development and myosin II regulatory light chain (RLC) phosphorylation. Resting tension is associated with a basal phosphorylation of 0.31 +/- 0.02 mol PO4/mol RLC, whereas upon LPA or thrombin treatment myosin II RLC phosphorylation increases to 1.08 +/- 0.05 and 0.82 +/- 0.05 mol PO4/mol RLC, respectively, within 2.5 min. Ca2+ chelation has minimal effect on the kinetics and magnitude of isometric tension development and RLC phosphorylation. Treatment of REF-52 cells with the Rho-kinase-specific inhibitor Y-27632 abolished thrombin- and LPA-stimulated contraction and RLC phosphorylation. These results suggest that Rho-kinase is sufficient to activate myosin II motor activity and contraction in REF-52 cells.
迄今为止,要确定钙/钙调蛋白依赖性肌球蛋白轻链激酶(MLCK)和钙非依赖性Rho激酶途径对肌球蛋白II激活和收缩的相对贡献一直很困难。在本研究中,我们表征了Rho激酶在一种大鼠胚胎成纤维细胞系(REF-52)中的作用,该细胞系中未检测到MLCK。通过蛋白质免疫印迹法或Northern印迹分析均未在REF-52细胞中检测到内源性MLCK。在存在或不存在钙离子的情况下,凝血酶或溶血磷脂酸(LPA)均可增加RhoA活性和Rho激酶活性,这与等长张力的发展和肌球蛋白II调节轻链(RLC)的磷酸化相关。静息张力与0.31±0.02 mol PO4/mol RLC的基础磷酸化相关,而在LPA或凝血酶处理后,肌球蛋白II RLC磷酸化在2.5分钟内分别增加至1.08±0.05和0.82±0.05 mol PO4/mol RLC。钙离子螯合对等长张力发展和RLC磷酸化的动力学和幅度影响最小。用Rho激酶特异性抑制剂Y-27632处理REF-52细胞可消除凝血酶和LPA刺激的收缩及RLC磷酸化。这些结果表明,Rho激酶足以激活REF-52细胞中的肌球蛋白II运动活性和收缩。